Exclusive B-cell phenotype of primary prostatic lymphomas. A potential role of chronic prostatitis.
Primary prostatic lymphomas (PPL) are exceedingly rare. Here, we have had the opportunity to investigate the largest series of PPL obtained from a nationwide expert pathologist network and thus try to understand the pathophysiology of these tumours. Up to 66000 cases of lymphomas have been collected and submitted to central expert review of the French Lymphopath network. We confirm the low frequency of PPL (n=77; 0.12%), all cases being of B-cell origin. Diffuse large B-cell lymphoma and small lymphocytic lymphoma were the most frequent subtypes, with 31% and 26% of cases, respectively, followed by MALT/lymphoplasmacytic lymphoma (19%), follicular lymphoma (12%), mantle cell lymphoma (6%), Burkitt lymphoma (4%) and unclassified lymphoma (1%). Clinical data obtained in 25 cases suggest that PPL are rather indolent tumours. Our hypothesis for B-cell recruitment in the prostatic tissue was the observation in chronic inflammation (prostatitis) of frequent heterotopic proliferation of high endothelial venules. The latter are dedicated to lymphocyte entry into secondary lymphoid organs, here putatively driving circulating clonal B-lymphocytes from the blood into the inflamed prostatic gland. This may account for the relative high incidence of small lymphocytic lymphoma cases consistently reported in series of primary or secondary prostatic lymphomas. Similar to other organs or glands, chronic inflammation may promote antigen-dependent intra-prostatic MALT lymphoma and diffuse large B-cell lymphoma development. Primary prostatic lymphomas are exclusively of B-cell origin and chronic inflammation through the proliferation of high endothelial venules could play some role in their development.